PineBridge Investments’s Organon & Co OGN Stock Holding History

PineBridge Investments’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,500	Closed	-$402K	–	574
2025 Q2	$402K	Sell	41,500 -2,282	-5%	-$23.5K	﹤0.01%	524
2025 Q1	$652K	Buy	+43,782	New	+$673K	0.01%	624
2021 Q3	–	Sell	-19,951	Closed	-$604K	–	645
2021 Q2	$604K	Buy	+19,951	New	+$657K	0.01%	549

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

PineBridge Investments's OGN Position: Q3 2025 in Review

PineBridge Investments sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 41,500 shares — an estimated $402K sold.

PineBridge Investments first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $652K in Q1 2025. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

PineBridge Investments reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
PineBridge Investments sold 41,500 Organon & Co shares in Q3 2025, an estimated $402K.
PineBridge Investments first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
PineBridge Investments's Organon & Co position peaked at $652K in Q1 2025.
670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on PineBridge Investments's 13F filing for Q3 2025, filed 14 Nov 2025.